Veranova, a leader in the development and manufacturing of specialty and complex active pharmaceutical ingredients (API) for the pharmaceutical and biotech sectors, has appointed Jacquelyn Martin as its new Chief Quality Officer (CQO).

Martin will assume global leadership of Veranova’s Quality and Regulatory functions, supporting the company’s continued drive for excellence in quality and compliance and growth in advanced pharmaceutical modalities.

“I am pleased to welcome Jacquelyn to Veranova as our new Chief Quality Officer,” said Mike Riley, CEO of Veranova. “She is a proven transformational leader who brings deep expertise in quality systems, regulatory compliance, and operational excellence. Her experience will be pivotal as we look to continually improve our quality systems and culture to support our growth and provide consistent and reliable service to our customers.”

Experience

Martin has more than 20 years of quality leadership experience in the pharmaceutical and CDMO sectors, with expertise spanning multiple modalities. She most recently served as Chief Quality and Regulatory Compliance Officer at Alcami Corporation, where she oversaw a global network of CDMO facilities and drove significant advancements in quality system maturity, inspection readiness, and quality culture.

Prior to Alcami, she held quality leadership positions at Gilead Sciences, AAIPharma Services, and TriPharm Services, and has served as an advisor to multiple companies on compliance and operational transformation. She holds a Bachelor of Science in Biology from the University of South Carolina–Columbia.

More Veranova News

Last year, Veranova expanded its Devens, Massachusetts facility.